ADR,SEQ,PT,HLT,HLGT,SOC_ABBREV,FATAL_YN
1,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
2,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
3,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
4,1,Paraesthesia,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
4,2,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
5,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
6,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
7,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
8,2,Chest discomfort,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,3,Facial pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
8,4,Neck pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
9,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
10,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
11,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
12,1,Rash,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
13,1,Oedema,Oedema NEC,General system disorders NEC,Genrl,N
13,2,Rash pruritic,"Rashes, eruptions and exanthems NEC",Epidermal and dermal conditions,Skin,N
14,1,Burning sensation,Paraesthesias and dysaesthesias,Neurological disorders NEC,Nerv,N
14,2,Swelling face,General signs and symptoms NEC,General system disorders NEC,Genrl,N
15,1,Asthma,Bronchospasm and obstruction,Bronchial disorders (excl neoplasms),Resp,N
16,1,Abdominal pain upper,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
16,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
17,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
18,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
19,1,Pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
19,2,Skin discolouration,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
19,3,Skin exfoliation,Exfoliative conditions,Epidermal and dermal conditions,Skin,N
20,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
20,2,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
21,1,Abdominal pain,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
21,2,Lip oedema,Oral soft tissue swelling and oedema,Oral soft tissue conditions,Gastr,N
22,1,Skin necrosis,Dermal and epidermal conditions NEC,Epidermal and dermal conditions,Skin,N
22,2,Sunburn,Radiation injuries,Injuries by physical agents,Inj&P,N
23,1,Migraine,Migraine headaches,Headaches,Nerv,N
23,2,Nausea,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
24,1,Abdominal rigidity,Gastrointestinal and abdominal pains (excl oral and throat),Gastrointestinal signs and symptoms,Gastr,N
25,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
26,1,Bladder cancer,Bladder neoplasms malignant,Renal and urinary tract neoplasms malignant and unspecified,Neopl,N
27,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
28,1,Anaphylactic shock,Anaphylactic and anaphylactoid responses,Allergic conditions,Immun,N
28,2,Dysphagia,Gastrointestinal signs and symptoms NEC,Gastrointestinal signs and symptoms,Gastr,N
28,3,Hypoacusis,Hearing losses,Hearing disorders,Ear,N
28,4,Hypoaesthesia oral,Oral soft tissue signs and symptoms,Oral soft tissue conditions,Gastr,N
28,5,Sneezing,Upper respiratory tract signs and symptoms,Respiratory tract signs and symptoms,Resp,N
28,6,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
29,1,Urticaria,Urticarias,Angioedema and urticaria,Skin,N
30,1,Subretinal fibrosis,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
30,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
31,1,Subretinal fibrosis,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
31,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
32,1,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
32,2,Subretinal fibrosis,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
32,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
33,1,Injection site cellulitis,Bacterial infections NEC,Bacterial infectious disorders,Infec,N
33,2,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
33,3,Injection site vesicles,Injection site reactions,Administration site reactions,Genrl,N
33,4,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
34,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
34,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
34,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
34,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
35,1,Blood pressure decreased,Vascular tests NEC (incl blood pressure),Cardiac and vascular investigations (excl enzyme tests),Inv,N
35,2,Cold sweat,Apocrine and eccrine gland disorders,Skin appendage conditions,Skin,N
35,3,Pallor,Site specific vascular disorders NEC,Vascular disorders NEC,Vasc,N
35,4,Syncope,Disturbances in consciousness NEC,Neurological disorders NEC,Nerv,N
36,1,Injection site extravasation,Injection site reactions,Administration site reactions,Genrl,N
37,1,Musculoskeletal stiffness,Musculoskeletal and connective tissue conditions NEC,Musculoskeletal and connective tissue disorders NEC,Musc,N
37,2,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
37,3,Oedema peripheral,Oedema NEC,General system disorders NEC,Genrl,N
38,1,Arrhythmia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
39,1,Dyspnoea,Breathing abnormalities,Respiratory disorders NEC,Resp,N
39,2,Hypersensitivity,Allergic conditions NEC,Allergic conditions,Immun,N
40,1,Heart rate irregular,Heart rate and pulse investigations,Cardiac and vascular investigations (excl enzyme tests),Inv,N
40,2,Hypotension,Vascular hypotensive disorders,Decreased and nonspecific blood pressure disorders and shock,Vasc,N
41,1,Tachycardia,Rate and rhythm disorders NEC,Cardiac arrhythmias,Card,N
42,1,Catheter site related reaction,Implant and catheter site reactions,Administration site reactions,Genrl,N
42,2,Extravasation,General signs and symptoms NEC,General system disorders NEC,Genrl,N
42,3,Thermal burn,Thermal burns,Injuries by physical agents,Inj&P,N
43,1,Intraocular pressure increased,Ophthalmic function diagnostic procedures,"Neurological, special senses and psychiatric investigations",Inv,N
43,2,Retinal pigment epithelial tear,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
43,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
44,1,Nipple exudate bloody,Breast signs and symptoms,Breast disorders,Repro,N
45,1,Choroidal infarction,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
45,2,Halo vision,Visual disorders NEC,Vision disorders,Eye,N
45,3,Retinal disorder,Ocular disorders NEC,Eye disorders NEC,Eye,N
45,4,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
46,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
46,2,Lacrimation increased,Lacrimation disorders,Eye disorders NEC,Eye,N
47,1,Macular oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
47,2,Retinal detachment,"Retinal structural change, deposit and degeneration","Ocular structural change, deposit and degeneration NEC",Eye,N
47,3,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
47,4,Retinal haemorrhage,Retinal bleeding and vascular disorders (excl retinopathy),"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
47,5,Retinal oedema,"Retinal, choroid and vitreous infections and inflammations","Ocular infections, irritations and inflammations",Eye,N
47,6,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
48,1,Dacryostenosis acquired,"Lid, lash and lacrimal structural disorders","Anterior eye structural change, deposit and degeneration",Eye,N
49,1,Affect lability,Affect alterations NEC,Mood disorders and disturbances NEC,Psych,N
49,2,Arthritis,Arthropathies NEC,Joint disorders,Musc,N
49,3,Balance disorder,Coordination and balance disturbances,Neurological disorders NEC,Nerv,N
49,4,Impaired reasoning,Thinking disturbances,Disturbances in thinking and perception,Psych,N
49,5,Tremor,Tremor (excl congenital),Movement disorders (incl parkinsonism),Nerv,N
49,6,Vomiting,Nausea and vomiting symptoms,Gastrointestinal signs and symptoms,Gastr,N
50,1,Disease recurrence,General signs and symptoms NEC,General system disorders NEC,Genrl,N
50,2,Treatment failure,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
50,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
51,1,Drug ineffective,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
51,2,Neoplasm progression,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
51,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
52,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
52,2,Neutrophil count decreased,White blood cell analyses,Haematology investigations (incl blood groups),Inv,N
52,3,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
53,1,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
53,2,Visual field defect,Visual field disorders,Vision disorders,Eye,N
54,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
54,2,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
55,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
55,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
55,3,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
55,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
55,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
56,1,Blindness,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
56,2,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
56,3,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
56,4,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
56,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
57,1,Neoplasm recurrence,Neoplasms unspecified malignancy and site unspecified NEC,Miscellaneous and site unspecified neoplasms malignant and unspecified,Neopl,N
57,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
57,3,Retinal exudates,Retinopathies NEC,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
57,4,Therapeutic response decreased,Therapeutic and nontherapeutic responses,Therapeutic and nontherapeutic effects (excl toxicity),Genrl,N
57,5,Visual acuity reduced,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
58,1,Choroidal neovascularisation,Choroid and vitreous haemorrhages and vascular disorders,"Retina, choroid and vitreous haemorrhages and vascular disorders",Eye,N
58,2,Product use in unapproved indication,"Medication errors, product use errors and issues NEC",Medication errors and other product use errors and issues,Inj&P,N
58,3,Visual impairment,Visual impairment and blindness (excl colour blindness),Vision disorders,Eye,N
59,1,Back pain,Musculoskeletal and connective tissue pain and discomfort,Musculoskeletal and connective tissue disorders NEC,Musc,N
59,2,Chest pain,Pain and discomfort NEC,General system disorders NEC,Genrl,N
